|Awarded On||February 21, 2019|
|Title||Rapid pathology evaluation system for biopsies|
|Program||Product Development Research|
|Award Mechanism||Seed Awards for Product Development Research|
|Principal Investigator/Program Director||Mei Wang|
|Cancer Sites||All Sites|
Seven million biopsy procedures are performed annually to diagnose cancer or collect tumor tissue for personalized therapy. Yet, due to inadequate biopsy tumor content, 1 in 5 biopsy procedures have to be repeated to confirm diagnosis, and thousands of patients can’t receive potentially life-saving therapies because of downstream test failures. If doctors can quickly test that a sample is insufficient they can collect more tissue immediately, but currently available tests are too slow and destructive and require dedicated personnel.
We will develop technology that re-envisions the way this testing is done by developing an Automated Digital Pathology Lab (ADPL) imaging system that updates th...